Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer

被引:41
作者
Murata, Yukiko [1 ]
Tatsugami, Katsunori [2 ]
Yoshikawa, Masahiro [1 ]
Hamaguchi, Masumitsu [1 ]
Yamada, Shigetomo [1 ]
Hayakawa, Yusuke [1 ]
Ueda, Kouhei [1 ]
Momosaki, Seiya [3 ]
Sakamoto, Naotaka [1 ,4 ]
机构
[1] Natl Hosp Org Kyushu Med Ctr, Dept Urol, Fukuoka, Japan
[2] Kyushu Univ, Dept Urol, Grad Sch Med Sci, Fukuoka, Japan
[3] Natl Hosp Org Kyushu Med Ctr, Dept Pathol, Fukuoka, Japan
[4] Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Fukuoka, Japan
关键词
intraductal carcinoma; predictive factors; prostatectomy; prostatic neoplasms; recurrence; RANDOMIZED CLINICAL-TRIAL; ADJUVANT RADIOTHERAPY; INTRADUCTAL CARCINOMA; PATHOLOGICAL STAGE; RADIATION-THERAPY; GLEASON SCORE; FOLLOW-UP; PROGRESSION; SURVIVAL; ANTIGEN;
D O I
10.1111/iju.13514
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. MethodsA total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. ResultsThe median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. ConclusionsIn D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 32 条
[1]   A Randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: Results at median follow-up of 102 months [J].
Akakura, Koichiro ;
Suzuki, Hiroyoshi ;
Ichikawa, Tomohiko ;
Fujimoto, Hiroyuki ;
Maeda, Osamu ;
Usami, Michiyuki ;
Hirano, Daisaku ;
Takimoto, Yukie ;
Kamoto, Toshiyuki ;
Ogawa, Osamu ;
Sumiyoshi, Yoshiteru ;
Shimazaki, Jun ;
Kakizoe, Tadao .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (12) :789-793
[2]   Is a limited lymph node dissection an adequate staging procedure for prostate cancer? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2002, 168 (02) :514-518
[3]   Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) [J].
Bolla, Michel ;
van Poppel, Hein ;
Tombal, Bertrand ;
Vekemans, Kris ;
Da Pozzo, Luigi ;
de Reijke, Theo M. ;
Verbaeys, Antony ;
Bosset, Jean-Francois ;
van Velthoven, Roland ;
Colombel, Marc ;
van de Beek, Cees ;
Verhagen, Paul ;
van den Bergh, Alphonsus ;
Sternberg, Cora ;
Gasser, Thomas ;
van Tienhoven, Geertjan ;
Scalliet, Pierre ;
Haustermans, Karin ;
Collette, Laurence .
LANCET, 2012, 380 (9858) :2018-2027
[4]  
Cohen RJ, 2000, PROSTATE, V43, P11, DOI 10.1002/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO
[5]  
2-B
[6]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[7]   Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy [J].
D'Amico, AV ;
Chen, MH ;
Roehl, KA ;
Catalona, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) :125-135
[8]   Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy [J].
Da Pozzo, Luigi F. ;
Cozzarini, Cesare ;
Briganti, Alberto ;
Suardi, Nazareno ;
Salonia, Andrea ;
Bertini, Roberto ;
Gallina, Andrea ;
Bianchi, Marco ;
Fantini, Gemma V. ;
Bolognesi, Angelo ;
Fazio, Ferruccio ;
Montorsi, Francesco ;
Rigatti, Patrizio .
EUROPEAN UROLOGY, 2009, 55 (05) :1003-1011
[9]   Extent of Pelvic Lymph Node Dissection and the Impact of Standard Template Dissection on Nomogram Prediction of Lymph Node Involvement [J].
Godoy, Guilherme ;
Chong, Kian Tai ;
Cronin, Angel ;
Vickers, Andrew ;
Laudone, Vincent ;
Touijer, Karim ;
Guillonneau, Bertrand ;
Eastham, James A. ;
Scardino, Peter T. ;
Coleman, Jonathan A. .
EUROPEAN UROLOGY, 2011, 60 (02) :195-201
[10]   Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance [J].
Guo, Charles C. ;
Epstein, Jonathan I. .
MODERN PATHOLOGY, 2006, 19 (12) :1528-1535